RMD · News · 20260809N
Revenue Performance and Mix
RESMED INC · 2026-08-09 · Importance 36 · Surprise 14 · No source text
ResMed reported fourth-quarter fiscal 2026 revenue growth of 9% year over year on a reported basis. Revenue increased 8% on a constant-currency basis, indicating a 1-percentage-point currency contribution to reported growth. Demand increased for sleep devices and masks, supporting the quarter’s revenue mix.
Key facts
- Analysts project ResMed 2027 revenues of US$5.80 billion. source
- Company's revenue growth is expected to slow to 2.6% annually (analyst expectation). source
- ResMed reported annual revenues of US$5.7 billion. source
- Fourth-quarter fiscal 2026 revenue growth: 9% on a reported basis, or 8% in constant currency. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | contingent | +1.0% | Analysts project ResMed 2027 revenues of US$5.80 billion. |
| revenue | negative | contingent | — | Company's revenue growth is expected to slow to 2.6% annually (analyst expectation). |
| revenue | unclear | realized | — | ResMed reported annual revenues of US$5.7 billion. |